Haihe Biopharma

China
Shaxi, Fujian, China

Company profile

Haihe Biopharma company profile

HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.

Business identity

Contact email
[email protected]
Phone number
86-(021)-20568888
Operating status
Active
Company type
For Profit
Employee range
101-250 employees
Revenue range
$10M-$100M
Founded
2011-01-01, Year

Headquarters

Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
2
Total equity funding
$317.6M
Last funding
Series B / $171M / 2020-07-24
Last equity funding
Series B / $171M
Investors
19
Lead investors
2
Founders
1
Articles
12

Founders and investors

Founders

Jian Ding

Lead investors

Huagai CapitalWarburg Pincus

Investors

3H Health InvestmentCSPC Pharmaceutical GroupHillhouse InvestmentLegend CapitalWarburg Pincus